Browsing by Author "Gion, María"
Now showing items 1-4 of 4
-
A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer
Sampayo-Cordero, Miguel; Miguel-Huguet, Bernat; Malfettone, Andrea; López-Miranda, Elena; Gion, María; Abad, Elena; Cortes, Javier (Frontiers Media, 2023-07-11) -
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
de la Cruz-Merino, Luis; Gion, María; Alonso Romero, José Luis; Quiroga, Vanesa; Moreno, Fernando; Cortés Castan, Javier; Cruz, Josefina (BMC, 2022-12-03) -
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
de la Cruz-Merino, Luis; Gion, María; Cruz Jurado, Josefina; Quiroga, Vanesa; Andrés, Raquel; Moreno, Fernando; Cortés Castan, Javier (MDPI, 2021-10-29) -
Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects
Gion, María; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Cortés Castan, Javier; Sampayo-Cordero, Miguel; Malfettone, Andrea (SAGE Publications, 2021-01-01)